Navigation Links
Promising hematologists begin year-long program to pursue careers in clinical research
Date:7/13/2009

(WASHINGTON, July 13, 2009) Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute.

The ASH Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research. The annual program begins with a week-long summer workshop that focuses on the fundamentals of research and includes practical information on topics such as how to form and sustain a multi-disciplinary research team, how to secure research funding, and how to navigate the regulatory rules governing clinical trials.

In addition to attending lectures and small-group discussions, participants work on their own proposed clinical research projects with input from expert faculty. Further mentoring opportunities are provided at two subsequent sessions, one at the ASH annual meeting in December and one the following spring.

"It is crucial to provide fellows and junior faculty with the chance to develop their clinical research skills," said ASH President Nancy Berliner, MD, Chief of Hematology at Brigham and Women's Hospital in Boston, and Professor of Medicine at Harvard Medical School. "But even more importantly, this program provides each participant with a supportive peer network and introduces them to leaders in hematology who will serve as mentors throughout their careers."

The 2009 ASH Clinical Research Training Institute participants are:

  • Karim Abou-Nassar, MD, University of Ottawa, Ottawa, Ontario, Canada
  • Paul M. Barr, MD, University Hospitals Case Medical Center, Cleveland, OH
  • Lucien Vandy Black, MD, University of Alabama at Birmingham, Birmingham, AL
  • Amanda B. Blair, MD, University of Texas Southwestern Medical Center, Dallas, TX
  • Amanda M. Brandow, DO, MS, Medical College of Wisconsin, Milwaukee, WI
  • Robert W. Chen, MD, City of Hope National Medical Center, Duarte, CA
  • Wei Ding, MD, PhD, Mayo Clinic, Rochester, MN
  • Melissa J. Frei-Jones, MD, MSCI, UT Health Science Center San Antonio, San Antonio, TX
  • Sumit Gupta, MD, Hospital for Sick Children, Toronto, Ontario, Canada
  • Richard H. Ko, MD, MHS, Children's Hospital Los Angeles, Los Angeles , CA
  • Holbrook E. Kohrt, MD, Stanford University School of Medicine, Palo Alto, CA
  • Kami J. Maddocks, MD, The Ohio State University, Columbus, OH
  • Peter Martin, MD, MS, Weill Cornell Medical College/Faculty of Medicine, New York, NY
  • Paul C. Moorehead, MD, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
  • Matthew J. Olnes, MD, PhD, National Heart, Lung, and Blood Institute, Bethesda, MD
  • Ran Reshef, MD, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
  • Mark A. Schroeder, MD, Washington University School of Medicine in St. Louis, St. Louis, MO
  • Nina Shah, MD, M. D. Anderson Cancer Center, Houston, TX
  • Nirmish Shah, MD, Duke University, Durham, NC
  • Robert F. Sidonio Jr., MD, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, PA

This program is offered to hematology and hematology/oncology fellows, as well as junior faculty who are within three years of completing their fellowship training at academic medical centers in the United States and Canada.


'/>"/>

Contact: Patrick C. Irelan
pirelan@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. Mount Sinai researchers find new Alzheimers disease treatment promising
2. Pistachio Industry Looks Toward a Promising 2009 Crop Year
3. Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health
4. Boston Heart Lab Named Most Promising Early Stage Company 2009 by Silicom Ventures
5. New Drug Promising Against Rheumatoid Arthritis
6. Respiratory Rally a Promising Practice in the Fight Against Chronic Disease
7. Promising Therapy for Prostate Cancer
8. Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer
9. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
10. 17 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences
11. CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... the addition of predictive analytics to its patient care management module. Using this ... even before a patient has been initiated on continuous positive airway pressure (CPAP), ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: